// App-Quantinova.ai

e12043 : BONADIUV trial: A single blind, randomized placebo controlled phase II study using oral ibandronate for osteopenic women receiving adjuvant aromatase inhibitors: Final safety analysis.

Researchers

Presenter

  • Lorenzo Livi

Principal Investigators

  • Icro Meattini

  • Vieri Scotti

  • Calogero Saieva

  • Isacco Desideri

  • Giulio Alberto Carta

  • Monica Lo Russo

  • Carla De Luca Cardillo

  • Daniela Greto

  • Jacopo Nori

  • Marco Bernini

  • Donato Casella

  • Lorenzo Orzalesi

  • Luis Jose Sanchez

  • Stefano M. Magrini

  • SImonetta Bianchi

Medical Centers

  • University of Florence, Florence, Italy

  • Florence University, Florence, Italy

  • ISPO Florence Cancer Center, Florence, Italy

  • Istituto Del Radio Alberti, Brescia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Ibandronic acid

  • Ergocalciferol

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • II

Study Id's

  • NCT02616744

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved